Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD

Gut. 2014 Dec;63(12):1843-53. doi: 10.1136/gutjnl-2014-307126. Epub 2014 Jun 26.
No abstract available

Keywords: IBD.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Antibodies, Monoclonal* / immunology
  • Antibodies, Monoclonal* / pharmacology
  • Antibodies, Monoclonal* / therapeutic use
  • Azathioprine / pharmacology*
  • Comparative Effectiveness Research
  • Disease Management
  • Drug Interactions
  • Drug Therapy, Combination / methods
  • Female
  • Humans
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use
  • Inflammatory Bowel Diseases / drug therapy*
  • Male
  • Mercaptopurine / pharmacology*
  • Methotrexate / pharmacology*
  • Outcome Assessment, Health Care
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha* / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha* / immunology

Substances

  • Antibodies, Monoclonal
  • Immunologic Factors
  • Tumor Necrosis Factor-alpha
  • Mercaptopurine
  • Azathioprine
  • Methotrexate